Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Hypha Labs (FUNI) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Hypha Labs (FUNI) over the last 16 years, with Q2 2025 value amounting to $454103.0.

  • Hypha Labs' Liabilities and Shareholders Equity fell 3964.33% to $454103.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $969715.0, marking a year-over-year decrease of 7664.67%. This contributed to the annual value of $493805.0 for FY2024, which is 6496.51% down from last year.
  • According to the latest figures from Q2 2025, Hypha Labs' Liabilities and Shareholders Equity is $454103.0, which was down 3964.33% from $256969.0 recorded in Q1 2025.
  • Hypha Labs' Liabilities and Shareholders Equity's 5-year high stood at $2.4 million during Q1 2022, with a 5-year trough of $256969.0 in Q1 2025.
  • For the 5-year period, Hypha Labs' Liabilities and Shareholders Equity averaged around $1.3 million, with its median value being $1.4 million (2022).
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 5099.4% in 2022, then tumbled by 8299.37% in 2024.
  • Hypha Labs' Liabilities and Shareholders Equity (Quarter) stood at $2.1 million in 2021, then tumbled by 44.33% to $1.2 million in 2022, then grew by 29.0% to $1.5 million in 2023, then plummeted by 82.99% to $258643.0 in 2024, then surged by 75.57% to $454103.0 in 2025.
  • Its Liabilities and Shareholders Equity stands at $454103.0 for Q2 2025, versus $256969.0 for Q1 2025 and $258643.0 for Q4 2024.